心血管疾病风险的转变从NAFLD到MAFLD
Zifeng Yang1,2, Juan Yang3,4, Jingjing Cai5
1Department of Cardiology, Renmin Hospital of Wuhan University, 430000 Wuhan, Hubei, China.
Reviews in cardiovascular medicine
|July 30, 2024
概括
与代谢相关的脂肪肝疾病 (MAFLD) 是一种与代谢问题相关的脂肪肝的新术语. 与非酒精性脂肪性肝病 (NAFLD) 患者相比,患有MAFLD的患者面临更高的心血管疾病和死亡风险.
科学领域:
- 肝病学 肝病学是一种肝病学.
- 心脏病学 心脏病学
- 代谢综合征是代谢综合征的一种.
背景情况:
- 非酒精性脂肪肝 (NAFLD) 负担随着超重和代谢综合征的流行增加.
- 建议更好地定义与代谢相关的脂肪肝疾病 (MAFLD),以更好地定义由于代谢障碍引起的脂肪肝.
- MAFLD和NAFLD种群显示差异,但也重叠,影响临床实践.
研究的目的:
- 系统地审查和比较NAFLD与MAFLD患者的心血管疾病 (CVD) 风险.
- 阐明这些患者群体中导致心血管疾病的潜在机制.
主要方法:
- 对新出现的证据进行系统审查.
- 对心血管疾病风险和死亡率数据的比较分析.
- 检查肝病和心血管疾病之间的病理生理机制.
主要成果:
- 在MAFLD患者中,代谢性并发症的患病率更高.
- 新出现的证据表明,MAFLD与NAFLD相比,所有原因和心血管死亡率的风险增加.
- 在NAFLD和MAFLD之间存在CVD风险概况和潜在机制的显著差异.
结论:
- 在NAFLD和MAFLD之间的区别对诊断和管理具有重要的临床影响.
- MAFLD是一个独立的实体,与NAFLD相比,其心血管风险可能更高.
- 需要进一步的研究,以充分了解和管理MAFLD患者心血管疾病风险.
更多相关视频
08:35A Model of Experimental Steatosis In Vitro: Hepatocyte Cell Culture in Lipid Overload-Conditioned Medium
Published on: May 18, 2021
6.3K
07:03Author Spotlight: Establishing MASLD Cell Models for Investigating Disease Mechanisms and the Lipid-Lowering Effects of Koumiss
Published on: July 19, 2024
848
相关概念视频
Inflammation
53.3K
Overview
53.3K
Overview of Lipid Metabolism
1.3K
Lipid metabolism is a crucial process in the human body that involves the synthesis and degradation of lipids. This process is essential for energy production, cell membrane formation, and hormone production, among other functions.
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
1.3K
Diseases of the Liver and Gallbladder
499
Liver and gallbladder diseases are a significant health concern, with prominent conditions including cirrhosis, hepatitis, non-alcoholic fatty liver disease (NAFLD), and gallstones. Jaundice is a common manifestation of liver and biliary disease.
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
499
Obesity
418
The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in...
418
Pathophysiology of Heart Failure
1.5K
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
1.5K
Cholesterol: Significance and Regulation
524
Although not a source of energy, cholesterol plays a significant role as a foundational structure for bile salts, steroid hormones, and vitamin D, as well as being a crucial component of plasma membranes. Approximately 15% of blood cholesterol is derived from our diet, with the remainder synthesized from acetyl CoA by the liver and intestines. Cholesterol is eliminated from the body through its conversion into bile salts, which are eventually discarded in the feces.
Considering cholesterol and...
Considering cholesterol and...
524
